{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:38:15Z","timestamp":1792460295331,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ajog.2016.10.016","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T16:02:41Z","timestamp":1478016161000},"page":"121-128.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":217,"title":["Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis"],"prefix":"10.1016","volume":"216","author":[{"given":"Shireen","family":"Meher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6721-5178","authenticated-orcid":false,"given":"Lelia","family":"Duley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Askie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajog.2016.10.016_bib1","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2016.10.016_bib2","first-page":"619","article-title":"CLASP: a randomized trial of low-dose\u00a0aspirin for the prevention and treatment of pre-eclampsia among 9364\u00a0pregnant women","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2016.10.016_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A\u00a0randomized trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group","volume":"105","author":"Golding","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.10.016_bib4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","article-title":"Barbados Low Dose Aspirin Study\u00a0in\u00a0Pregnancy (BLASP): a randomized\u00a0trial for\u00a0the prevention of pre-eclampsia and its\u00a0complications","volume":"105","author":"Rotchell","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.10.016_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2016.10.016_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jama.1991.03470020086038","article-title":"A\u00a0meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease","volume":"266","author":"Imperiale","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2016.10.016_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/uog.12470","article-title":"Aspirin for pre-eclampsia: beware of subgroup meta-analysis","volume":"41","author":"Meher","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib8","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2016.10.016_bib9","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2016.10.016_bib10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(94)92452-X","article-title":"Follow-up of children in the Italian Study of Aspirin in Pregnancy","volume":"343","author":"Parazzini","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2016.10.016_bib11","first-page":"861","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy","volume":"102","year":"1994","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.10.016_bib12","unstructured":"National Institute for Health and Care Excellence. Hypertension in Prenancy. Management of Hypertensive Disorders in Pregnancy. NICE clinical guideline no. 107. Issued 2010, updated January 2011. Available at: http:\/\/www.nice.org.uk\/nicemedia\/live\/13098\/50418\/50418.pdf. Accessed May 8,\u00a02015."},{"key":"10.1016\/j.ajog.2016.10.016_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1701-2163(15)30588-0","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Practice Bulletin no. 307, May 2014. Executive Summary","volume":"36","author":"Magee","year":"2014","journal-title":"Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2016.10.016_bib14","doi-asserted-by":"crossref","unstructured":"Lowe SA, Bowyer L, Lust K, et\u00a0al. SOMANZ guideline for the management of hypertensive disorders of pregnancy 2014. Available at: https:\/\/somanz.org\/documents\/HTPregnancyGuidelineJuly2014. Accessed May 8,\u00a02014.","DOI":"10.1111\/ajo.12253"},{"key":"10.1016\/j.ajog.2016.10.016_bib15","first-page":"1122","article-title":"Report of the ACOG Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib16","series-title":"WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia","year":"2011"},{"key":"10.1016\/j.ajog.2016.10.016_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2393-5-7","article-title":"Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis","volume":"5","year":"2005","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2016.10.016_bib20","series-title":"Maternal physiology and pathology. The current status of gynaecology and obstetrics series","first-page":"183","article-title":"Low-dose aspirin in the prevention of pre-eclampsia: current evaluation","author":"Michael","year":"1992"},{"key":"10.1016\/j.ajog.2016.10.016_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1440-1797.1995.tb00043.x","article-title":"Prevention of pre-eclampsia in high risk women with renal disease: a prospective randomized trial of heparin and dipyridamole","volume":"1","author":"Kincaid Smith","year":"1995","journal-title":"Nephrology"},{"key":"10.1016\/j.ajog.2016.10.016_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09513.x","article-title":"ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnancies","volume":"103","year":"1996","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.10.016_bib23","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0140-6736(91)93124-R","article-title":"Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial","volume":"337","author":"Uzan","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2016.10.016_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (ERASME) (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.10.016_bib25","first-page":"161","article-title":"Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches","volume":"109","author":"Vainio","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.10.016_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9378(89)80079-1","article-title":"Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy","volume":"160","author":"Uzan","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib27","unstructured":"Railton A, Davey DA. Aspirin and dipyridamole in the prevention of pre-eclampsia: effect on plasma 6 keto PGF1alpha and TxB2 and clinical outcome of pregnancy. Presented at the 1st European Congress on Prostaglandins in Reproduction, July 6-9, 1988, Vienna, Austria, page\u00a048."},{"key":"10.1016\/j.ajog.2016.10.016_bib28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.HYP.0000047876.63997.EE","article-title":"Administration time-dependant influence of aspirin on blood pressure in pregnant women","volume":"41","author":"Hermida","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2016.10.016_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.218","article-title":"Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine Doppler at 23 weeks gestation","volume":"22","author":"Yu","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women","volume":"329","author":"Sibai","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.10.016_bib31","unstructured":"August P, Helseth G, Edersheim TG, Hutson JM, Druzin M. Sustained release, low-dose aspirin ameliorates but does not prevent preeclampsia (PE) in a high risk population. In: Presented at the 9th International Congress, International Society for the Study of Hypertension in Pregnancy, March 15-18, 1994, Sydney, Australia, page\u00a072."},{"key":"10.1016\/j.ajog.2016.10.016_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk","volume":"338","author":"Caritis","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.10.016_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0020-7292(97)00257-9","article-title":"A\u00a0randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia","volume":"60","author":"Byaruhanga","year":"1998","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2016.10.016_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0029-7844(95)00340-1","article-title":"A\u00a0randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow","volume":"87","author":"Morris","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib35","first-page":"238","article-title":"A\u00a0prospective randomized placebo-controlled trial of low dose aspirin for prevention of intra uterine growth retardation","volume":"109","author":"Wang","year":"1996","journal-title":"Chin Med J"},{"key":"10.1016\/j.ajog.2016.10.016_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/10641959909023076","article-title":"Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension","volume":"18","author":"Rogers","year":"1999","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2016.10.016_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0929-8266(96)00203-0","article-title":"Effect of low dose aspirin treatment on vascular resistance in the uterine, uteroplacental, renal and umbilical arteries\u2014a prospective longitudinal study on a high risk population with persistent notch in the uterine arteries","volume":"5","author":"Zimmermann","year":"1997","journal-title":"Eur J Ultrasound"},{"key":"10.1016\/j.ajog.2016.10.016_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2016.10.016_bib39","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-9378(93)90351-I","article-title":"Low-dose aspirin therapy to prevent preeclampsia","volume":"168","author":"Hauth","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib40","unstructured":"Kincaid-Smith P. Trial to evaluate the role of aspirin (60 mg) in the prevention of idiopathic intrauterine growth retardation and pregnancy induced hypertension in primigravid women with abnormal uterine artery waveforms on Doppler examination at 22\u201324 weeks gestation. Personal communication, Oct. 30,\u00a01991."},{"key":"10.1016\/j.ajog.2016.10.016_bib41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0140-6736(93)92988-6","article-title":"Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian Study of Aspirin in Pregnancy","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2016.10.016_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/10641959709031640","article-title":"Low-dose aspirin in high-risk pregnancy","volume":"16","author":"Gallery","year":"1997","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2016.10.016_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0301-2115(03)00269-0","article-title":"A\u00a0small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia","volume":"112","author":"Chiaffarino","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2016.10.016_bib44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jch.12541","article-title":"Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis","volume":"17","author":"Xu","year":"2015","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.ajog.2016.10.016_bib45","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/jama.1990.03440100097014","article-title":"The existence of publication bias and risk factors for its occurrence","volume":"263","author":"Dickersin","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2016.10.016_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.6215","article-title":"Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo controlled double-blind study","volume":"32","author":"Haapsamo","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00404-006-0162-y","article-title":"Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history","volume":"274","author":"Tarim","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2016.10.016_bib48","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/AOG.0b013e31823234ad","article-title":"Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function","volume":"118","author":"Han","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1469-0705.2000.00009.x","article-title":"Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial","volume":"15","author":"Grab","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0143-4004(83)80043-5","article-title":"Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy","volume":"4","author":"Pijnenborg","year":"1983","journal-title":"Placenta"},{"issue":"Suppl A","key":"10.1016\/j.ajog.2016.10.016_bib51","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.placenta.2005.02.010","article-title":"Priming and remodelling of human placental bed spiral arteries during pregnancy-a review","volume":"26","author":"Lyall","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2016.10.016_bib52","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/hr.2011.111","article-title":"Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation","volume":"34","author":"Bakhti","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2016.10.016_bib53","first-page":"826","article-title":"Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial","volume":"46","author":"Ebrashy","year":"2005","journal-title":"Croat Med J"},{"key":"10.1016\/j.ajog.2016.10.016_bib54","first-page":"98","article-title":"Effect of aspirin for prevention of preeclampsia in women with abnormal ultrasonic findings in uterine artery","volume":"15","author":"Mesdaghinia","year":"2011","journal-title":"Feyz J Kashan Univ Med Sci"},{"key":"10.1016\/j.ajog.2016.10.016_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2016.10.016_bib56","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/humrep\/dep245","article-title":"Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in\u00a0vitro fertilization and early pregnancy","volume":"24","author":"Lambers","year":"2009","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2016.10.016_bib57","first-page":"148","article-title":"The effect of low-dose acetylsalicylic acid (ASA) on control of hypertensive in pregnancy","volume":"25","author":"Vaseie","year":"2006","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2016.10.016_bib58","first-page":"265","article-title":"Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS","volume":"10","author":"Jamal","year":"2012","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.ajog.2016.10.016_bib59","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital abnormalities: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2016.10.016_bib60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816309115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937816309115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:12:44Z","timestamp":1757589164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937816309115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0002937816309115"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2016.10.016","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2016.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}